Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,300
Closed -$315K 1133
2023
Q3
$315K Hold
1,300
﹤0.01% 962
2023
Q2
$312K Hold
1,300
﹤0.01% 969
2023
Q1
$244K Hold
1,300
﹤0.01% 1014
2022
Q4
$276K Hold
1,300
﹤0.01% 1025
2022
Q3
$204K Buy
+1,300
New +$207K ﹤0.01% 1152
2022
Q1
Sell
-1,100
Closed -$239K 1443
2021
Q4
$239K Hold
1,100
﹤0.01% 1243
2021
Q3
$208K Sell
1,100
-600
-35% -$109K ﹤0.01% 1244
2021
Q2
$300K Hold
1,700
﹤0.01% 1154
2021
Q1
$279K Buy
+1,700
New +$260K ﹤0.01% 1150

Other funds holding MEDP

Gabelli Funds's MEDP Position: Q4 2023 in Review

Gabelli Funds sold out of Medpace (MEDP) in Q4 2023, closing a stake of 1,300 shares — an estimated $315K sold.

Gabelli Funds first reported a position in MEDP in Q1 2021 and held it in 9 quarters. The position peaked at $315K in Q3 2023. 544 funds tracked by Wall St. Rank hold MEDP as of Q4 2023.

  • Gabelli Funds reported no remaining Medpace position as of Q4 2023 after selling out during the quarter.
  • Gabelli Funds sold 1,300 Medpace shares in Q4 2023, an estimated $315K.
  • Gabelli Funds first reported a position in Medpace in Q1 2021 and held it in 9 quarters.
  • Gabelli Funds's Medpace position peaked at $315K in Q3 2023.
  • 544 funds tracked by Wall St. Rank held Medpace as of Q4 2023.

Based on Gabelli Funds's 13F filing for Q4 2023, filed 13 Feb 2024.